Literature DB >> 7734341

Tobacco smoke condensate cutaneous carcinogenesis: changes in Langerhans' cells and tumour regression.

N A Zeid1, H K Muller.   

Abstract

Tobacco smoke condensate was painted on the skin of BALB/c mice. It increased the density and changed the morphology of Langerhans' cells (LC). LC number in epidermal sheets of treated mice was significantly higher (1793 LC/mm2) than in controls (946 LC/mm2) (P < 0.0001) and remained elevated for 35 weeks. LC became less dendritic, or even rounded in shape, and smaller in size. The function of the morphologically altered LC was impaired when assessed by the contact hypersensitivity response. These changes were associated with skin tumour development in all treated mice. Ten weeks after stopping the TSC treatment, LC number in skin tumours and in skin around these lesions had not decreased, but significantly increased (P < 0.0001). During this period tumour regression occurred in 23% of tumours; the remaining tumours showed a 50% reduction in size. At 45 weeks, the LC number in epidermal sheets around skin papillomas was 2274 +/- 14.14/mm2 and in invasive squamous cell carcinomas was 2088 +/- 183/m2. This was associated with reversible changes in LC morphology, where cells became fully dendritic. This also correlated with lymphocytic infiltration into tumours, tumour necrosis, reduction in tumour size and/or tumour regression. It is concluded that the influx of normal LC into the skin tumours allowed the development of an immune response with tumour regression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734341      PMCID: PMC1997142     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  26 in total

1.  Experimental investigations on the possible carcinogenic effects of tobacco smoking.

Authors:  H DRUCKREY
Journal:  Acta Med Scand Suppl       Date:  1961

2.  Subpopulations of Langerhans' cells in cervical neoplasia.

Authors:  S K Tay; D Jenkins; P Maddox; M Campion; A Singer
Journal:  Br J Obstet Gynaecol       Date:  1987-01

3.  Langerhans' cell density in the normal exocervical epithelium and in the cervical intraepithelial neoplasia.

Authors:  I Caorsi; C D Figueroa
Journal:  Br J Obstet Gynaecol       Date:  1986-09

4.  Langerhans' cells and T cells in human skin tumours: an immunohistological study.

Authors:  K C Gatter; H B Morris; B Roach; P Mortimer; K A Fleming; D Y Mason
Journal:  Histopathology       Date:  1984-03       Impact factor: 5.087

5.  Tumor antigen presentation by murine epidermal cells.

Authors:  S Grabbe; S Bruvers; R L Gallo; T L Knisely; R Nazareno; R D Granstein
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

6.  Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma.

Authors:  J P McArdle; B A Knight; G M Halliday; H K Muller; G Rowden
Journal:  Pathology       Date:  1986-04       Impact factor: 5.306

7.  S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival.

Authors:  N A Zeid; H K Muller
Journal:  Pathology       Date:  1993-10       Impact factor: 5.306

8.  Control of Langerhans' cell density by a skin tumour-derived cytokine.

Authors:  G M Halliday; A D Lucas; R S Barnetson
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 9.  Antigen presentation in the skin: modulation by u.v. radiation and chemical carcinogens.

Authors:  H K Muller; C Bucana; M L Kripke
Journal:  Semin Immunol       Date:  1992-08       Impact factor: 11.130

10.  Carcinogenic action of cigarette smoke condensate on mouse skin.

Authors:  T D Day
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

View more
  1 in total

1.  Tobacco smoke-induced immunologic changes may contribute to oral carcinogenesis.

Authors:  Michael Schierl; Daxesh Patel; Wanhong Ding; Amit Kochhar; Katayun Adhami; Xi Kathy Zhou; Andrew J Dannenberg; Richard D Granstein
Journal:  J Investig Med       Date:  2014-02       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.